agents for treating anorexia gall bladder stasis agents for treating postoperative paralytic ileus agents for treating scleroderma agents for treating intestinal pseudo obstruction anti gastritis agents anti emesis agents anti constipation agents for treating irritable bowel syndrome agents for treating functional dyspepsia and agents for treating colonic hypomotility the listing of the above agents include those agents disclosed in the pdr the above other therapeutic agents when employed in combination with the compounds of the present invention may be used for example in those amounts indicated in the pdr or as otherwise determined by one of ordinary skill in the art the compounds of the formula i can be administered for any of the uses described herein by any suitable means for example orally such as in the form of tablets capsules granules or powders sublingually bucally parenterally such as by subcutaneous intravenous intramuscular or intrasternal injection or infusion techniques e g as sterile injectable aqueous or non aqueous solutions or suspensions nasally including administration to the nasal membranes such as by inhalation spray topically such as in the form of a cream or ointment or rectally such as in the form of suppositories in dosage unit formulations containing non toxic pharmaceutically acceptable vehicles or diluents the present compounds can for example be administered in a form suitable for immediate release or extended release immediate release or extended release can be achieved by the use of suitable pharmaceutical compositions comprising the present compounds or particularly in the case of extended release by the use of devices such as subcutaneous implants or osmotic pumps the present compounds can also be administered liposomally.